-+ 0.00%
-+ 0.00%
-+ 0.00%

BTIG Reiterates Buy on Abivax, Maintains $150 Price Target

Benzinga·02/25/2026 09:41:13
Listen to the news
BTIG analyst Julian Harrison reiterates Abivax (NASDAQ:ABVX) with a Buy and maintains $150 price target.